IL10 and arthritic joint disease: Reduction of disease severity and progression of arthritis in relation with decrease of Th17 cells and increase of IL-10 producing T cells.At least 3 i.v. injections of 1 × 106 tolDCs are needed for an optimal therapeutic effect